Drug intelligence / Profile preview

TT12

Development stage
Preclinical
Lead developer
Tessa Therapeutics
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, TCR-Engineered T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

**TT12** is a human papillomavirus specific T cell therapy (HPVST) developed for the treatment of HPV-associated cancers. It leverages engineered T cells targeting HPV antigens to elicit antitumor immune responses, primarily evaluated in oropharyngeal cancer and cervical cancer. This cell-based immunotherapy aims to provide durable responses in HPV-driven malignancies by harnessing T cell-mediated cytotoxicity against infected or transformed cells expressing HPV oncoproteins.

02

Targets

Human papillomavirus type 18 E6/E7 peptide-MHC class I complexHPV16 E6/HLA-A*02:01 (HPV16 E6 peptide-HLA-A*02:01 complex)

Beyond the preview

Go deeper on TT12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TT12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call